Subject: Carrington Labs Taps Meister for Two Posts 
Date: Published: 10/16/90 (29 lines)
Source: Wall Street Journal. Copyright Dow Jones & Co. Inc.

    Who's News:
    Carrington Labs Taps
    Meister for Two Posts
    On an Interim Basis

    IRVING, Texas -- Carrington Laboratories Inc. said that
 Karl H. Meister, a New York investment banker, was named
 interim president and chief executive officer, succeeding
 Clinton H. Howard, who retired effective last Friday.

[23 lines irrelevant to AIDS were removed.  -- sysop]

    Carrington has been accused of making overly broad claims
 about its Carrisyn drug, by, for instance, indicating that it
 may be effective in the treatment of AIDS.  However,
 Carrington has charged that the criticism has come from a
 campaign by short sellers seeking to profit from a drop in
 its stock.
    In national over-the-counter trading yesterday, Carrington
 closed at $6.25, down $1.25.

[This article is made available here by Dow Jones Co. for the 
personal and non-commercial use of callers to this bbs, in the 
hope that it will be of some help to those who are suffering 
from the disease and others who are seeking to help them.]